Monoclonal antibodies specific for discontinuous epitopes direct refolding of influenza A virus hemagglutinin
- PMID: 20047763
- PMCID: PMC2814887
- DOI: 10.1016/j.molimm.2009.10.023
Monoclonal antibodies specific for discontinuous epitopes direct refolding of influenza A virus hemagglutinin
Abstract
Antibodies (Abs) specific for the globular domain of influenza A virus hemagglutinin (HA) efficiently neutralize viral infectivity and provide the most effective protection against influenza following infection or vaccination. Nearly all neutralizing Abs recognize discontinuous determinants formed by residues present on different stretches of the HA primary structure. Here, I show that approximately 25% of a large panel of neutralizing monoclonal Abs (mAbs), including Abs specific for each of the four major antigenic sites, can bind to completely denatured HA. Binding of these mAbs to denatured HA occurs much more slowly than binding to native HA, but bound mAbs dissociate from denatured and native HA with similar kinetics, and amino acid substitutions that reduce mAb binding to native HA have a similar effect on mAb interaction with denatured HA. HA refolding induced by mAb binding facilitated the binding of mAbs to other antigenic sites, indicating that refolding was not limited to the antibody-interaction domain. These findings validate the localization of antigenic sites by identifying amino acid substitutions selected in mAb escape mutants. Further, they demonstrate that Abs can facilitate the refolding of denatured proteins, which suggests a number of practical applications for optimizing antibody based assays, and also for potentially using Abs as specific chaperones for protein refolding.
Published by Elsevier Ltd.
Figures



Similar articles
-
Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.J Virol. 2014 Nov;88(21):12364-73. doi: 10.1128/JVI.01381-14. Epub 2014 Aug 13. J Virol. 2014. PMID: 25122788 Free PMC article.
-
Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.Influenza Other Respir Viruses. 2013 May;7(3):480-90. doi: 10.1111/irv.12029. Epub 2012 Nov 5. Influenza Other Respir Viruses. 2013. PMID: 23122228 Free PMC article.
-
Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.J Virol. 2007 Dec;81(23):12911-7. doi: 10.1128/JVI.01522-07. Epub 2007 Sep 19. J Virol. 2007. PMID: 17881439 Free PMC article.
-
The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.Mol Immunol. 2013 Dec;56(4):705-19. doi: 10.1016/j.molimm.2013.07.010. Epub 2013 Aug 7. Mol Immunol. 2013. PMID: 23933511 Review.
-
Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.J Immunol Methods. 2018 Oct;461:23-29. doi: 10.1016/j.jim.2018.07.007. Epub 2018 Jul 24. J Immunol Methods. 2018. PMID: 30053389 Free PMC article. Review.
Cited by
-
Viewing folding of nascent polypeptide chains from ribosomes.Expert Rev Proteomics. 2012 Dec;9(6):579-81. doi: 10.1586/epr.12.57. Expert Rev Proteomics. 2012. PMID: 23256666 Free PMC article. No abstract available.
-
Influenza A virus hemagglutinin trimerization completes monomer folding and antigenicity.J Virol. 2013 Sep;87(17):9742-53. doi: 10.1128/JVI.00471-13. Epub 2013 Jul 3. J Virol. 2013. PMID: 23824811 Free PMC article.
-
High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.Clin Vaccine Immunol. 2012 Jul;19(7):1012-8. doi: 10.1128/CVI.00081-12. Epub 2012 May 9. Clin Vaccine Immunol. 2012. PMID: 22573737 Free PMC article.
-
Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines.PLoS One. 2016 Oct 6;11(10):e0164245. doi: 10.1371/journal.pone.0164245. eCollection 2016. PLoS One. 2016. PMID: 27711176 Free PMC article.
-
Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.J Virol. 2012 Jan;86(2):1214-26. doi: 10.1128/JVI.06189-11. Epub 2011 Nov 16. J Virol. 2012. PMID: 22090110 Free PMC article.
References
-
- Air GM, Laver WG, Webster RG. Antigenic variation in influenza viruses. Contrib Microbiol Immunol. 1987;8:20–59. - PubMed
-
- Benkovic SJ. Catalytic antibodies. Annu Rev Biochem. 1992;61:29–54. - PubMed
-
- Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) Cell. 1982;31:417–427. - PubMed
-
- Caton AJ, Stark SE, Kavaler J, Staudt LM, Schwartz D, Gerhard W. Many variable region genes are utilized in the antibody response of BALB/c mice to the influenza virus A/PR/8/34 hemagglutinin. J Immunol. 1991;147:1675–1686. - PubMed
-
- Eisenlohr LC, Gerhard W, Hackett CJ. Acid-induced conformational modification of the hemagglutinin molecule alters interaction of influenza virus with antigen-presenting cells. Journal of Immunology. 1988;141:1870–1876. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources